211 related articles for article (PubMed ID: 30930289)
41. NMS-873 functions as a dual inhibitor of mitochondrial oxidative phosphorylation.
Bouwer MF; Hamilton KE; Jonker PB; Kuiper SR; Louters LL; Looyenga BD
Biochimie; 2021 Jun; 185():33-42. PubMed ID: 33727138
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo.
Song EJ; Españo E; Shim SM; Nam JH; Kim J; Lee K; Park SK; Lee CK; Kim JK
Sci Rep; 2021 May; 11(1):9427. PubMed ID: 33941825
[TBL] [Abstract][Full Text] [Related]
43. Antiviral effect of catechins in green tea on influenza virus.
Song JM; Lee KH; Seong BL
Antiviral Res; 2005 Nov; 68(2):66-74. PubMed ID: 16137775
[TBL] [Abstract][Full Text] [Related]
44. A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein.
Chang SY; Park JH; Kim YH; Kang JS; Min JY
Biochem Biophys Res Commun; 2016 Mar; 471(2):282-9. PubMed ID: 26850850
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of influenza virus replication by adlay tea.
Nagai E; Iwai M; Koketsu R; Sogabe R; Morimoto R; Suzuki Y; Ohta Y; Okuno Y; Ohshima A; Enomoto T; Isegawa Y
J Sci Food Agric; 2018 Mar; 98(5):1899-1905. PubMed ID: 28902408
[TBL] [Abstract][Full Text] [Related]
46. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
[TBL] [Abstract][Full Text] [Related]
47. Antiviral activity of KR-23502 targeting nuclear export of influenza B virus ribonucleoproteins.
Jang Y; Lee HW; Shin JS; Go YY; Kim C; Shin D; Malpani Y; Han SB; Jung YS; Kim M
Antiviral Res; 2016 Oct; 134():77-88. PubMed ID: 27565992
[TBL] [Abstract][Full Text] [Related]
48. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
49. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.
Tarbet EB; Vollmer AH; Hurst BL; Barnard DL; Furuta Y; Smee DF
Arch Virol; 2014 Jun; 159(6):1279-91. PubMed ID: 24311151
[TBL] [Abstract][Full Text] [Related]
50. Antiviral Activity of Peanut (Arachis hypogaea L.) Skin Extract Against Human Influenza Viruses.
Makau JN; Watanabe K; Mohammed MMD; Nishida N
J Med Food; 2018 Aug; 21(8):777-784. PubMed ID: 29847745
[TBL] [Abstract][Full Text] [Related]
51. Update: influenza activity - United States, September 28, 2008--January 31, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(5):115-9. PubMed ID: 19214161
[TBL] [Abstract][Full Text] [Related]
52. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
[TBL] [Abstract][Full Text] [Related]
53. Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy.
Perwitasari O; Yan X; Johnson S; White C; Brooks P; Tompkins SM; Tripp RA
Antimicrob Agents Chemother; 2013 Jan; 57(1):475-83. PubMed ID: 23129053
[TBL] [Abstract][Full Text] [Related]
54. Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model.
Laure M; Hamza H; Koch-Heier J; Quernheim M; Müller C; Schreiber A; Müller G; Pleschka S; Ludwig S; Planz O
Antiviral Res; 2020 Jun; 178():104806. PubMed ID: 32304723
[TBL] [Abstract][Full Text] [Related]
55. Update: influenza activity--United States, September 28-November 29, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(49):1329-32. PubMed ID: 19078922
[TBL] [Abstract][Full Text] [Related]
56. Global monitoring of antiviral resistance in currently circulating human influenza viruses, November 2011.
Wkly Epidemiol Rec; 2011 Nov; 86(45):497-501. PubMed ID: 22128380
[No Abstract] [Full Text] [Related]
57. Human miR-3145 inhibits influenza A viruses replication by targeting and silencing viral PB1 gene.
Khongnomnan K; Makkoch J; Poomipak W; Poovorawan Y; Payungporn S
Exp Biol Med (Maywood); 2015 Dec; 240(12):1630-9. PubMed ID: 26080461
[TBL] [Abstract][Full Text] [Related]
58. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
59. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
60. Influenza virus surveillance by the Instituto Adolfo Lutz, influenza season 2014: antiviral resistance.
Santos KC; Silva DB; Benega MA; Paulino Rde S; Silva ER; Pereira Ddos S; Mussi AD; Silva VC; V Gubareva L; Paiva TM
Rev Inst Med Trop Sao Paulo; 2015; 57(1):92. PubMed ID: 25651335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
